Asie · Marchés régionaux · Vietnam Investment Review

Chinese medicine manufacturer initiates clinical heart trial in Singapore

Publié par Vietnam Investment Review · Vietnam il y a 18 h

Traditional Chinese medicine producer Tong Ren Tang announced clinical trials for its flagship cardiovascular formulation during a global medical conference hosted in Singapore.

Lire l'article complet sur Vietnam Investment Review Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (vir.com.vn)

Chinese medicine manufacturer initiates clinical heart trial in Singapore

À lire aussi

Fujiyama Power Systems share price falls 15% in a month: Is 45% upside still on the table? Check DAM Capital target

AI-discovered PHP flaws trigger global security warnings

Sensex Today | Stock Market LIVE Updates: Nifty slumps below 22,600; Tata Motors PV at 52-wk low

Swiggy slips 26% in 1 month, hits record low; stock down 46% from IPO price

Prices, rents of industrial space rise in Q3 amid resilient demand, low interest rates

Singapore security robotics firm Kabam to cease operations on Nov 20

Chinese medicine manufacturer initiates clinical heart trial in Singapore

Partager

À lire aussi

Fujiyama Power Systems share price falls 15% in a month: Is 45% upside still on the table? Check DAM Capital target

AI-discovered PHP flaws trigger global security warnings

Sensex Today | Stock Market LIVE Updates: Nifty slumps below 22,600; Tata Motors PV at 52-wk low

Swiggy slips 26% in 1 month, hits record low; stock down 46% from IPO price

Prices, rents of industrial space rise in Q3 amid resilient demand, low interest rates

Singapore security robotics firm Kabam to cease operations on Nov 20